{{Cite journal| doi = 10.1007/s41669-019-0130-7| issn = 2509-4254| volume = 3| issue = 4| pages = 505–515| last1 = Garay| first1 = Osvaldo Ulises| last2 = Nishimwe| first2 = Marie Libérée| last3 = Bousmah| first3 = Marwân-Al-Qays| last4 = Janah| first4 = Asmaa| last5 = Girard| first5 = Pierre-Marie| last6 = Chêne| first6 = Geneviève| last7 = Moinot| first7 = Laetitia| last8 = Sagaon-Teyssier| first8 = Luis| last9 = Meynard| first9 = Jean-Luc| last10 = Spire| first10 = Bruno| last11 = Boyer| first11 = Sylvie| title = Cost-effectiveness analysis of lopinavir/ritonavir monotherapy versus standard combination antiretroviral therapy in HIV-1 infected patients with viral suppression in France (ANRS 140 DREAM)| journal = PharmacoEconomics - Open| date = 2019-12}}